NEW YORK (GenomeWeb News) – Monsanto has acquired agricultural biotechnology firm GrassRoots Biotechnology for an undisclosed amount.

The acquisition was made earlier this month, and in an e-mail to GenomeWeb Daily News, a Monsanto spokesperson said, "GrassRoots focuses on gene expression and other agricultural technologies that will complement Monsanto's biotechnology research and development work."

All research employees will be offered positions at Monsanto. The spokesperson declined to disclose further terms of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.